在西方国家，胃癌治愈性切除后的长期生存率仍然很低，缺乏有效的辅助化疗促使人们试用新辅助化疗（术前化疗）的效果。自1988年以来，作者已开始新辅助化疗的第H期临床试验（5一氟尿喀院和顺铂，依托泪耷、阿霉素和顺铂，5氟尿防院、干扰素。和顺铂）。作者本次研究美国辛辛那 In Western countries, the long-term survival rate after curative resection of gastric cancer is still very low, and lack of effective adjuvant chemotherapy has prompted people to try the effect of neoadjuvant chemotherapy (preoperative chemotherapy). Since 1988, the authors have begun Phase II clinical trials of neoadjuvant chemotherapy (5-fluorouracil and cisplatin, relying on tears, doxorubicin and cisplatin, 5-fluorouracil, and interferon. platinum). The author of this study Cincinnati, USA